Pharmaceutical industry

Our niche in pharmaceutical development is the discovery phase. We design, manage, and analyze sequencing experiments of cell lines and animal models to determine the mode of action of a compound, for example. In practice, this means transcriptomic, epigenomic and functional genomics studies.

Retrospective studies with genome-wide measurements of responders and non-responders is another phase where we can come to your aide. Integration of genetics with clinical variables can lead to identification of biomarkers for re-purposing of lead molecules.

Get free information package about bioinformatics as a service to your email in pdf-form.

Modern drug development leverages sequencing-based bioinformatics in the very early stages – especially in target identification, lead validation, and mode of action studies.

Matti Nykter
Matti Nykter CSO, co-founder Genevia Technologies Oy

See our customer cases in other areas: